Both Rotterdam and Maastricht have a longstanding tradition in research on mitochondrial diseases (since respectively 1976 and 1995). From 1997 onwards, the universities ErasmusMC en Maastricht UMC+ are closely cooperating on this topic. In the form of Mi2Cure, this cooperation has grown into an official centre of expertise. Our goal is map complex mitochondrial diseases, to conduct research, and to develop (genetic) therapies. This website informs about the ongoing research projects, the partipating investigators and links with patient organisations.
Verslag van ENMC conferentie voor mogelijk nieuwe therapie voor DNA onderhouds- of (delings) ziekten
Mi2Cure is researching this therapy for diseases including MNGIE, POLG1,TK2 and RRM2B. During the weekend of the 16th through 18th June 2017, fifteen clinicians, basic scientists, patient relatives, and pharmaceutical representatives met in Heemskerk, The Netherlands. The delegates...